Cytokinetics (CYTK)
NASDAQ: CYTK
· Real-Time Price · USD
38.95
0.28 (0.72%)
At close: Aug 18, 2025, 3:59 PM
39.43
1.22%
After-hours: Aug 18, 2025, 07:31 PM EDT
Cytokinetics Revenue
Cytokinetics reported an annual revenue of $18.47M, reflecting a 145.34% growth. For the quarter ending June 30, 2025, Cytokinetics generated $66.77M in revenue.
Revenue (ttm)
18.47M
Revenue Growth
145.34%
Price / Sales Ratio
285.13
Revenue / Employee
37.1K
Employees
498
Market Cap
4.66B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 18.47M | +145.34% |
Dec 31, 2023 | 7.53M | -92.04% |
Dec 31, 2022 | 94.59M | +34.30% |
Dec 31, 2021 | 70.43M | +26.15% |
Dec 31, 2020 | 55.83M | +107.79% |
Dec 31, 2019 | 26.87M | -14.71% |
Dec 31, 2018 | 31.5M | +135.64% |
Dec 31, 2017 | 13.37M | -87.44% |
Dec 31, 2016 | 106.41M | +271.30% |
Dec 31, 2015 | 28.66M | -38.95% |
Dec 31, 2014 | 46.94M | +53.16% |
Dec 31, 2013 | 30.65M | +305.45% |
Dec 31, 2012 | 7.56M | +88.98% |
Dec 31, 2011 | 4M | +55.22% |
Dec 31, 2010 | 2.58M | -96.84% |
Dec 31, 2009 | 81.54M | +556.51% |
Dec 31, 2008 | 12.42M | -8.82% |
Dec 31, 2007 | 13.62M | +335.63% |
Dec 31, 2006 | 3.13M | -64.91% |
Dec 31, 2005 | 8.91M | -33.70% |
Dec 31, 2004 | 13.44M | +27.09% |
Dec 31, 2003 | 10.58M | -7.19% |
Dec 31, 2002 | 11.4M | +34.61% |
Dec 31, 2001 | 8.47M | +Infinity% |
Dec 31, 2000 | 0 | n/a |